Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
39.84
+0.44 (1.12%)
Jan 23, 2026, 3:00 PM CST
Revenue by Product
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Diagnostic Reagents | 519.74M | Log In | Log In | Log In | Log In | Upgrade |
Diagnostic Reagents Growth | 19.22% | Log In | Log In | Log In | Log In | Upgrade |
Original Design Manufacturer | - | Log In | Log In | Log In | Log In | Upgrade |
Original Brand Manufacturer | - | Log In | Log In | Log In | Log In | Upgrade |
Other Business | - | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Infectious Disease Detection Series | - | Log In | Log In | Log In | Log In | Upgrade |
Infectious Disease Detection Series Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Drug Abuse (Drugs) Testing Series | - | Log In | Log In | Log In | Log In | Upgrade |
Drug Abuse (Drugs) Testing Series Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Reproductive Health Testing Series | - | Log In | Log In | Log In | Log In | Upgrade |
Reproductive Health Testing Series Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Myocardial Marker Detection Series | - | Log In | Log In | Log In | Log In | Upgrade |
Myocardial Marker Detection Series Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Tumor Marker Detection Series | - | Log In | Log In | Log In | Log In | Upgrade |
Tumor Marker Detection Series Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other Series | - | Log In | Log In | Log In | Log In | Upgrade |
Other Series Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Overseas | 392.68M | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 27.43% | Log In | Log In | Log In | Log In | Upgrade |
China | 127.05M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -0.56% | Log In | Log In | Log In | Log In | Upgrade |
North America | - | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Asia | - | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Latin America | - | Log In | Log In | Log In | Log In | Upgrade |
Latin America Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Africa | - | Log In | Log In | Log In | Log In | Upgrade |
Africa Growth | - | Log In | Log In | Log In | Log In | Upgrade |